Miraculins Announces Closing of Private Placement Offering
26 Mai 2014 - 11:43PM
Marketwired
Miraculins Announces Closing of Private Placement Offering
WINNIPEG, MANITOBA--(Marketwired - May 26, 2014) - Miraculins
Inc. (TSX-VENTURE:MOM) (the "Company"), a medical diagnostic
company focused on acquiring, developing and commercializing
diagnostic tests and risk assessment technologies for unmet
clinical needs, has closed its recently announced private placement
offering (the "Offering") with aggregate gross proceeds to the
Company of $260,000 from the sale of 2,600,000 units ("Units") at a
price of $0.10 per Unit. Each Unit is comprised of one common share
of the Company (a "Share") and one Share purchase warrant (a
"Warrant").
Each whole Warrant entitles the holder to purchase one Share at
a price of $0.15 per Share for a period of twenty-four months from
the date the Warrant is issued. The Shares and Warrants will be
restricted from transfer for a period of four months and a day from
the date hereof in accordance with applicable securities laws. The
net proceeds of the Offering shall be used for general corporate
purposes.
One finder assisted the Company by introducing a subscriber to
the Offering and was paid a finder's fee of 10% of the total
subscription proceeds received from the subscriber introduced to
the Company by the finder.
A director of the Company, James Mellon, through an investment
company that he controls, subscribed for 1,450,000 Units for gross
proceeds of $145,000. In addition, the wife of another Company
director subscribed for 50,000 Units for gross proceeds of $5,000.
These transactions are "related party transactions" for the
purposes of Multilateral Instrument 61-101 Protection of
Minority Security Holders in Special Transactions ("MI
61-101"). The Company is relying on an exemption from the minority
approval and formal valuation requirements of MI 61-101 due to the
fact that the value of these transactions does not represent
greater than 25% of the market capitalization of the Company.
The closing of the Offering is subject to the final approval of
the TSX Venture Exchange.
Neither the TSX Venture Exchange nor its Regulation Services
Provider (as that term is defined in the policies of the TSX
Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
Miraculins Inc.Christopher J. MoreauPresident &
CEO204-477-7599204-453-1596info@miraculins.comwww.miraculins.com
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Miraculins Inc. (TSXV:MOM)
Historical Stock Chart
Von Jul 2023 bis Jul 2024
Echtzeit-Nachrichten über (TSX Venture Börse): 0 Nachrichtenartikel
Weitere Miraculins Inc. News-Artikel